This is Part Two of a series on Supportive Oligonucleotide Therapy (SOT), a form of antisense oligonucleotide therapy. SOT is a personalized, gene-silencing treatment designed to disrupt pathogens like Lyme disease. Read Part One here. By Maria Marian, ND, MSE The idea of... Read More »



























